None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Inborn neonates 300/7 to 366/7 weeks of gestation 2. Written informed parental consent obtained before participation in the study
Exclusion criteria
Exclusion criteria: i. Neonates born at gestation less than 30 weeks or more than or equal to 37 weeks ii. Outborn neonates iii. Multiple gestation iv. Major lethal congenital anomalies or known/suspected chromosomal anomalies v. Fetal hydrops vi. Rh isoimmunization vii. Cord prolapse, cord abnormalities such as true knots viii. Shortumbilical cordlength ix. No parental consent x. Residence beyond 20 kms radius from our unit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine venous hematocritTimepoint: AT 48 HOURS OF LIFE | — |
Secondary
| Measure | Time frame |
|---|---|
| a. Hct at 6 weeks of postnatal age b. Bilirubin level at 12 , 48 hours of postnatal age. c. Serum ferritin at 6 wks of age d. Heart rate, mean blood pressure in the first 48 hours of life e. Hyperbilirubinemia requiring phototherapy f. Symptomatic polycythemia in first 48 hours g. Incidence of hemodynamically significant patent ductus arteriosus,NEC (Stage 2 and above), IVH on cranial ultrasound(grade3andabove), ROP(stage2andabove) and BPD h. Total number of PRBC transfusions till 6 weeks of postnatal age i. Duration of hospital stay j. Death up to 6weeks of postnatal age Timepoint: 12 hours,48 hours and at 6 weeks of life | — |
Countries
India
Contacts
Associate Professor